Modulation of brain cholesterol: A new line of research in Alzheimer's disease treatment?

by Institut National de la Sante et de la Recherche MedicaleFluorescent labelling of the Tau protein in a hNT human cell. Credit: ©Inserm/U837We have known for some years that Alzheimer&#39

Updated on: February 26,2024

Modulation of brain cholesterol: A new line of research in Alzheimer's disease treatment?

by Institut National de la Sante et de la Recherche MedicaleFluorescent labelling of the Tau protein in a hNT human cell. Credit: ©Inserm/U837We have known for some years that Alzheimer&#39

Updated on:February 26,2024

Does persistent pain impact older adults' physical function, cognition, and well-being?

by WileyCredit: Unsplash/CC0 Public DomainIn a study in theJournal of the American Geriatrics Societyof 5,589 US adults aged 65 years and older, persistent pain was common and was lin

Updated on: February 05,2024

Does persistent pain impact older adults' physical function, cognition, and well-being?

by WileyCredit: Unsplash/CC0 Public DomainIn a study in theJournal of the American Geriatrics Societyof 5,589 US adults aged 65 years and older, persistent pain was common and was lin

Updated on:February 05,2024

Team reports major breakthrough in understanding Alzheimer's disease

by Trinity College DublinA human donor Alzheimer's disease brain tissue stained with an agent called 'congo-red', which allows for the visualization of amyloid-beta plaques (red) in t

Updated on: February 26,2024

Team reports major breakthrough in understanding Alzheimer's disease

by Trinity College DublinA human donor Alzheimer's disease brain tissue stained with an agent called 'congo-red', which allows for the visualization of amyloid-beta plaques (red) in t

Updated on:February 26,2024

Alzheimer's-disease-related proteases control axonal guidance by regulating growth cone dynamics

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.BACE1 is the major drug target for Alzheimer's

Updated on: February 26,2024

Alzheimer's-disease-related proteases control axonal guidance by regulating growth cone dynamics

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.BACE1 is the major drug target for Alzheimer's

Updated on:February 26,2024

Potential new biomarker for Alzheimer's discovered

by Max Delbrück Center for Molecular MedicineThe Arl8b protein (turquoise) shows an accumulation around the amyloid-b aggregates (red). Cell nuclei are stained blue. The section was analyzed with

Updated on: April 20,2024

Potential new biomarker for Alzheimer's discovered

by Max Delbrück Center for Molecular MedicineThe Arl8b protein (turquoise) shows an accumulation around the amyloid-b aggregates (red). Cell nuclei are stained blue. The section was analyzed with

Updated on:April 20,2024

Brain-inspired neural networks reveal insights into biological basis of relational learning

Updated on: February 28,2025

Brain-inspired neural networks reveal insights into biological basis of relational learning

Updated on:February 28,2025

An implant to prevent Alzheimer's

by Ecole Polytechnique Federale de LausanneAn infographic of how the implanted capsule releases antibodies to the brain. Credit: Patrick Aebischer (EPFL)In a cutting-edge treatment for Alzheimer&

Updated on: February 28,2024

An implant to prevent Alzheimer's

by Ecole Polytechnique Federale de LausanneAn infographic of how the implanted capsule releases antibodies to the brain. Credit: Patrick Aebischer (EPFL)In a cutting-edge treatment for Alzheimer&

Updated on:February 28,2024

Diabetes drug shows promise for safely treating, detecting Alzheimer's disease

by Boston University Medical CenterAs the number of patients with Alzheimer's disease (AD) rapidly increases, new treatments as well as blood tests that are simple and can be easily performed

Updated on: March 07,2024

Diabetes drug shows promise for safely treating, detecting Alzheimer's disease

by Boston University Medical CenterAs the number of patients with Alzheimer's disease (AD) rapidly increases, new treatments as well as blood tests that are simple and can be easily performed

Updated on:March 07,2024

Children found to use the same brain network as adults for tough problems

by The Ohio State UniversityCredit: Pixabay/CC0 Public DomainChildren as young as 4 years old show evidence of a network in the brain found in adults that tackles difficult cognitive problems, a

Updated on: May 13,2024

Children found to use the same brain network as adults for tough problems

by The Ohio State UniversityCredit: Pixabay/CC0 Public DomainChildren as young as 4 years old show evidence of a network in the brain found in adults that tackles difficult cognitive problems, a

Updated on:May 13,2024

Alzheimer's researchers find clues to toxic forms of amyloid beta

by University of California - Santa CruzDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Much of the research on Alzheimer's disease has focused

Updated on: April 16,2024

Alzheimer's researchers find clues to toxic forms of amyloid beta

by University of California - Santa CruzDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Much of the research on Alzheimer's disease has focused

Updated on:April 16,2024

Homocysteine tied to Alzheimer's via A-beta-fibrinogen interaction

(HealthDay)—Plasma homocysteine (HC) and its metabolite homocysteine thiolactone (HCTL) contribute to Alzheimer's disease (AD) pathology via the amyloid-β (Aβ)-fibrinogen interaction, according to

Updated on: February 28,2024

Homocysteine tied to Alzheimer's via A-beta-fibrinogen interaction

(HealthDay)—Plasma homocysteine (HC) and its metabolite homocysteine thiolactone (HCTL) contribute to Alzheimer's disease (AD) pathology via the amyloid-β (Aβ)-fibrinogen interaction, according to

Updated on:February 28,2024

Common heart drug may slow progression of Huntington's disease

Common heart drug may slow progression of Huntington's diseasebyUniversity of Iowaβ-Blocker Use in Participants With Motor-Manifest Huntington Disease (mmHD) Was Associated With Slower Rate

Updated on: December 16,2024

Common heart drug may slow progression of Huntington's disease

Common heart drug may slow progression of Huntington's diseasebyUniversity of Iowaβ-Blocker Use in Participants With Motor-Manifest Huntington Disease (mmHD) Was Associated With Slower Rate

Updated on:December 16,2024